EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

TREM ‐1 Pathway Biomarkers for Classification of Periodontal Diseases and Monitoring of Treatment Response in Grade B and C Periodontitis

Angelika Silbereisen iD, Ronaldo Lira-Junior iD, Beral Afacan, Ozgen-Veli Özturk, Gülnur Emingil, Nagihan Bostanci iD

Journal of Clinical Periodontology · 2025

DOI: 10.1111/jcpe.14195 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Periodontology, 2025. Verfasst von Angelika Silbereisen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oral Health and Periodontology, Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Triggering Receptor Expressed on Myeloid Cells-1, Periodontitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Vetenskapsrådet, Steering Group KI/Region Stockholm for Dental Research, Karolinska Institutet's Strategic Funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study investigated the diagnostic potential of salivary triggering receptor expressed on myeloid cells (TREM)‐1, peptidoglycan recognition protein 1 (PGLYRP1) and interleukin (IL)‐1β for periodontitis patients and their ability to predict treatment outcome.

Methods

Systemically healthy, non‐smokers with gingivitis ( n = 31), stage III periodontitis (34 grade B: n = 34, grade C: n = 24) and healthy controls ( n = 34) were recruited. Periodontitis patients ( n = 42) underwent non‐surgical periodontal treatment. Saliva was collected at baseline (T0) and post‐treatment (T1, T3, T6). Biomarkers were measured using immunoassays. Periodontitis patients were categorised into responders ( n = 19) and non‐responders ( n = 23) based on the number of residual pockets ≥ 5 mm with bleeding on probing at T6.

Results

TREM‐1 was higher in periodontitis than in gingivitis and health, and in periodontitis grade B than in gingivitis ( p < 0.05). PGLYRP1 and IL‐1β were higher in periodontitis and gingivitis compared to controls ( p < 0.01). All biomarkers discriminated periodontitis from health (AUC ≥ 0.9) with high sensitivity (82.1%–92.8%) and specificity (83.3%–88.9%). TREM‐1 differentiated periodontitis from gingivitis (AUC = 0.72) with high sensitivity (92.8%) but low specificity (58.1%). Baseline biomarkers did not predict treatment outcome (AUC ≤ 0.61), while T1 levels showed moderate potential (AUC ≥ 0.71).

Conclusions

Salivary TREM‐1 pathway biomarkers offer diagnostic value for periodontitis, are modulated by therapy but show limited ability to predict treatment outcome. Study Registration The study has been registered in ClinicalTrials.gov (ID: NCT06715176, 4 December 2024).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triggering Receptor Expressed on Myeloid Cells-1PeriodontitisHumansBiomarkersMaleFemaleMiddle AgedAdultSalivaInterleukin-1betaGingivitisTreatment OutcomeCase-Control Studies

Stichwörter der Autor:innen

PGLYRP1TREM‐1periodontal treatmentperiodontitissaliva

Substanzen

Triggering Receptor Expressed on Myeloid Cells-1BiomarkersInterleukin-1betaTREM1 protein, human

Autor:innen und Institutionen

  • Division of Oral Health and Periodontology, Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Division of Oral Diagnostics and Surgery, Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Department of Periodontology, Faculty of Dentistry, Aydın Adnan Menderes University, Aydın, Turkey.
  • Department of Periodontology, School of Dentistry, İstinye University, Istanbul, Turkey.

ORCID-Profile: Angelika Silbereisen, Ronaldo Lira-Junior, Nagihan Bostanci

Förderung

  • Vetenskapsrådet
  • Steering Group KI/Region Stockholm for Dental Research
  • Karolinska Institutet's Strategic Funds

Zitieren

APA

Silbereisen, A., Lira-Junior, R., Afacan, B., Özturk, O. V., Emingil, G., & Bostanci, N. (2025). TREM ‐1 Pathway Biomarkers for Classification of Periodontal Diseases and Monitoring of Treatment Response in Grade B and C Periodontitis. Journal of Clinical Periodontology. https://doi.org/10.1111/jcpe.14195

Vancouver

Silbereisen A, Lira-Junior R, Afacan B, Özturk OV, Emingil G, Bostanci N. TREM ‐1 Pathway Biomarkers for Classification of Periodontal Diseases and Monitoring of Treatment Response in Grade B and C Periodontitis. Journal of Clinical Periodontology. 2025. doi:10.1111/jcpe.14195

BibTeX
@article{Silbereisen2025,
  author = {Silbereisen, Angelika and Lira-Junior, Ronaldo and Afacan, Beral and Özturk, Ozgen-Veli and Emingil, Gülnur and Bostanci, Nagihan},
  title = {TREM ‐1 Pathway Biomarkers for Classification of Periodontal Diseases and Monitoring of Treatment Response in Grade B and C Periodontitis},
  journal = {Journal of Clinical Periodontology},
  year = {2025},
  doi = {10.1111/jcpe.14195}
}
Kostenlos starten →